SCIENTIFIC EXCHANGE 2023: A Journey to The Top; The Past, Present, and Future of Probiotics Applications in Human Wellbeing
Renowned scientists from around the world gathered in Montreal at the occasion of the 12th edition of Scientific Exchange event, organized by the Rosell® Institute for Microbiome and Probiotics by Lallemand, on February 15-16.
The SciEx conference program and poster presentations provided an open platform to share scientific findings in recent published and unpublished preclinical and clinical research, conducted in collaboration with Lallemand Health Solutions probiotic strains, spark innovative ideas and discussions, and nourish new partnerships.
“SciEx is an internal conference with some of our international collaborators where we encourage discussions and sharing about research and development as well as results. With this year’s thematic, we wanted to build on current knowledge in microbiome research and leverage this comprehension to stir innovative ideas for future projects. The key takeaway message from the sessions is how the gut microbiota has become a focal point of interest to potentially influence quality of life in fields as diversified as weight management, women’s fertility, infantile spasm, or amyotrophic lateral sclerosis,” expressed Sylvie Binda, vice-president of research and development at Lallemand Health Solutions. “Probiotics have the potential to improve quality of life in a growing number of conditions and health applications. We would like to thank all our valued partners,” she concludes.
If you would like to collaborate and develop a project with probiotics, please contact our team.
ABOUT RESEARCH AND DEVELOPMENT AT LALLEMAND HEALTH SOLUTIONS
The major R&D challenges focus on the development and characterization of the effects of first and new generation probiotics on human health. Lallemand Health Solutions has integrated platforms for preclinical, clinical, galenic and bioprocess development, and a dedicated R&D team of 40 people, notably managing some twenty clinical trials on five continents. The division’s production plants operate according to Good Manufacturing Practices (GMP), including one site holding a manufacturing authorization according to GMP for medicinal products for human use (Saint-Simon, France).
SCIEX CONFERENCE PROGRAM:
METABOLIC HEALTH PLATFORM
The Use of Prebiotics and Probiotics in Obesity, Weight Management, And Glycemic Index Control, by Julie-Anne Nazare, Lyon University
Probiotic Supplementation in Obesity: What Are the Benefits, by Angelo Tremblay, Université Laval
Probiotics For Vascular Inflammation in The Metabolic Syndrome: The PROMISE Study, by Anil Nigam, Montreal Heart Institute
WOMEN HEALTH PLATFORM
The Application of Probiotics in Women Health and Fertility Applications, by Leonides Fernández, Complutense University of Madrid
Application Of Probiotic Strains in Women’s Health, by Taylor C. Judkins, University of Florida
GUT-BRAIN AXIS PLATFORM
Probiotic Treatment and Diet Affect Maternal Care, Inflammation, Metabolic Markers and The Offspring Stress Response in Long-Evans Rats, by M. Elizabeth O’Leary, Dalhousie University
Gut Microbiota Manipulation in Pediatric Neurodevelopmental Disorders, by Chunlong Mu, University of Calgary
Probiotics As Therapeutics for Neurodegeneration, by Alex Parker, Université de Montréal
EXPLORATORY PLATFORM
Efficacy Of Probiotics Taken During the In Acute Phase Of COVID-19 To Reduce the Occurrence Of Long COVID (PROVID-LD): A Randomized Controlled Trial Protocol, by Jean-Charles Pasquier, Sherbrook University
Impact Of Probiotic Supplementation on Exercise Endurance Among Non-Elite Athletes: A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial, by Caitlin E. McDermott, University of Florida
State-Of-The-Art Metagenomics, by Jeremie Auger, Lallemand Health Solutions
THE FUTURE OF PROBIOTICS
Next Generation Strain Development and Potential Applications, by Yolanda Sanz, Spanish Superior Council of Scientific Research
Nimble Science: Small Intestine Microbiome Aspiration (Simba) Capsule, by Sabina Bruehlmann, CEO at Nimble Science
Preserving Health Of The Microbial Human -Change In Paradigm, by Joël Doré, French National Research Institute for Agriculture, Food and Environment (INRAE)
Media contact
Marilou Luneau, Responsable de contenu
Lallemand Health Solutions
mluneau@lallemand.com
